Experts from Mayo Clinic, UT-Houston Medical School, TCID participating in TB symposium Dec. 2-4, 2008

Tuesday, December 2, 2008

Physicians and researchers from the Mayo Clinic, the University of Texas-Houston Medical School, and the Texas Center for Infectious Disease will speak at a tuberculosis symposium that begins today, Tuesday, Dec. 2, and continues through Thursday, Dec. 4, at The University of Texas Health Science Center at Tyler, 11937 U.S. Highway 271.

The “Tuberculosis Intensive” is designed to give health care professionals the latest data on how best to treat patients with TB and those who are at high risk for TB.

Among the highlights of the symposium:

Timothy Aksamit, MD, of the Mayo Clinic, and David Griffith, MD, a UTHSCT pulmonologist who specializes in TB, will present “The Epidemiology of TB." Epidemiology is the study of the causes, distributions, and control of disease in populations.

Lisa Armitage, MD, PhD, UT-Houston Medical School, will present “TB/HIV."

Bob Longfield, MD, UTHSCT, at the Texas Center for Infectious Disease in San Antonio, will present “Extrapulmonary TB."

Barbara Seaworth, MD, medical director of the Heartland National TB Center, will discuss drug-resistant TB.

The Heartland Center is a joint project between UTHSCT and the Texas Department of State Health Services.

Founded in 2005, the center is funded by a five-year, $7.5 million grant from the CDC.

It provides training, technical assistance, and medical consultation for TB in a 13-state region consisting of Texas, Oklahoma, New Mexico, Arizona, Missouri, Illinois, Iowa, Wisconsin, Minnesota, Kansas, Nebraska, South Dakota, and North Dakota.

NOTICE: Protected health information is subject to electronic disclosure.